Legal Representation
Attorney
Harold Milstein
USPTO Deadlines
Next Deadline
155 days remaining
NOA E-Mailed - SOU Required
Due Date
June 03, 2026
Extension Available
Until December 03, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 10, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 10, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 10, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 3, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 12, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 11, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 11, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 19, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 19, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 19, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 7, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 7, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 7, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 18, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for the detection of cancer; diagnostic antibody biomarker reagents for medical purposes, namely, for the diagnosis of cancer.
Additional Information
Pseudo Mark
PET FORTY SIX
Pseudo Mark
PET FOUR SIX
Classification
International Classes
005